Logo image of BRVO.CA

BRAVO MINING CORP (BRVO.CA) Stock Fundamental Analysis

TSX-V:BRVO - TSX Venture Exchange - CA10566M1068 - Common Stock - Currency: CAD

2.03  +0.02 (+1%)

Fundamental Rating

2

Overall BRVO gets a fundamental rating of 2 out of 10. We evaluated BRVO against 822 industry peers in the Metals & Mining industry. While BRVO seems to be doing ok healthwise, there are quite some concerns on its profitability. BRVO does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

BRVO had negative earnings in the past year.
BRVO had a negative operating cash flow in the past year.
BRVO.CA Yearly Net Income VS EBIT VS OCF VS FCFBRVO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 -5M -10M -15M

1.2 Ratios

BRVO has a Return On Assets of -3.04%. This is in the better half of the industry: BRVO outperforms 78.42% of its industry peers.
The Return On Equity of BRVO (-3.12%) is better than 80.48% of its industry peers.
Industry RankSector Rank
ROA -3.04%
ROE -3.12%
ROIC N/A
ROA(3y)-5.58%
ROA(5y)N/A
ROE(3y)-5.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BRVO.CA Yearly ROA, ROE, ROICBRVO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 -2 -4 -6 -8

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BRVO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BRVO.CA Yearly Profit, Operating, Gross MarginsBRVO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

6

2. Health

2.1 Basic Checks

Compared to 1 year ago, BRVO has more shares outstanding
Compared to 1 year ago, BRVO has an improved debt to assets ratio.
BRVO.CA Yearly Shares OutstandingBRVO.CA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 20M 40M 60M 80M 100M
BRVO.CA Yearly Total Debt VS Total AssetsBRVO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

BRVO has an Altman-Z score of 65.32. This indicates that BRVO is financially healthy and has little risk of bankruptcy at the moment.
BRVO has a Altman-Z score of 65.32. This is amongst the best in the industry. BRVO outperforms 92.48% of its industry peers.
BRVO has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.01, BRVO is in line with its industry, outperforming 50.79% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 65.32
ROIC/WACCN/A
WACCN/A
BRVO.CA Yearly LT Debt VS Equity VS FCFBRVO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 20M 40M

2.3 Liquidity

BRVO has a Current Ratio of 25.91. This indicates that BRVO is financially healthy and has no problem in meeting its short term obligations.
BRVO has a better Current ratio (25.91) than 94.30% of its industry peers.
A Quick Ratio of 25.91 indicates that BRVO has no problem at all paying its short term obligations.
BRVO has a better Quick ratio (25.91) than 94.30% of its industry peers.
Industry RankSector Rank
Current Ratio 25.91
Quick Ratio 25.91
BRVO.CA Yearly Current Assets VS Current LiabilitesBRVO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 10M 20M 30M

2

3. Growth

3.1 Past

BRVO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 49.69%, which is quite impressive.
EPS 1Y (TTM)49.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, BRVO will show a very strong growth in Earnings Per Share. The EPS will grow by 79.05% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y33.32%
EPS Next 2Y9.54%
EPS Next 3Y-6.27%
EPS Next 5Y79.05%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BRVO.CA Yearly Revenue VS EstimatesBRVO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2028 2029 2030 50M 100M 150M 200M
BRVO.CA Yearly EPS VS EstimatesBRVO.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2028 2029 2030 0 0.1 0.2 0.3 0.4

0

4. Valuation

4.1 Price/Earnings Ratio

BRVO is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BRVO.CA Price Earnings VS Forward Price EarningsBRVO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BRVO.CA Per share dataBRVO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

BRVO's earnings are expected to decrease with -6.27% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.54%
EPS Next 3Y-6.27%

0

5. Dividend

5.1 Amount

No dividends for BRVO!.
Industry RankSector Rank
Dividend Yield N/A

BRAVO MINING CORP

TSX-V:BRVO (3/7/2025, 7:00:00 PM)

2.03

+0.02 (+1%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-14 2024-11-14/amc
Earnings (Next)04-03 2025-04-03
Inst Owners13.74%
Inst Owner ChangeN/A
Ins Owners53.22%
Ins Owner ChangeN/A
Market Cap221.41M
Analysts80
Price Target5.05 (148.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.6%
PT rev (3m)-12%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)16.65%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.74
P/tB 2.74
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)-0.15
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0.74
TBVpS0.74
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.04%
ROE -3.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-5.58%
ROA(5y)N/A
ROE(3y)-5.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 43967.4%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 25.91
Quick Ratio 25.91
Altman-Z 65.32
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)132909%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)49.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y33.32%
EPS Next 2Y9.54%
EPS Next 3Y-6.27%
EPS Next 5Y79.05%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y5.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year28.57%
EBIT Next 3Y25.99%
EBIT Next 5Y118.08%
FCF growth 1Y-88.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8.19%
OCF growth 3YN/A
OCF growth 5YN/A